Patents by Inventor Allan Wachter

Allan Wachter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6124257
    Abstract: Compositions and methods of treating disease and injuries wherein by sequentially or co-administering pulmonarily a polypeptide effective for the treatment of the injury or disease and a protease inhibitor capable of binding with elastase or cathepsin G.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: September 26, 2000
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 6096327
    Abstract: Cosmetic compositions and methods are provided for revitalizing the skin especially where it is placed in an environment which can cause injury to the skin. The compositions contain an effective amount of a protease inhibitor to provide a prophylactic or repairing effect.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: August 1, 2000
    Assignee: Protease Sciences Inc.
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 6085742
    Abstract: The invention provides an inhalation device for administering a medicament within a prescribed dosage range to avoid over or under administration. The device contains in the mouthpiece or nozzle a channel which follows the Poiseuille equation and provides a flow rate of the fluid containing the medicament at a flow rate of between 0.5 and 3.0 l/s.
    Type: Grant
    Filed: April 17, 1998
    Date of Patent: July 11, 2000
    Assignee: Aeromax Technologies, Inc.
    Inventors: Allan Wachter, Stuart Lindsay
  • Patent number: 5869063
    Abstract: Compositions and methods are provided for treating the skin especially where it is placed in an environment which can cause injury or inflammation to the skin. The compositions contain an effective amount of the extract from marama beans.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: February 9, 1999
    Assignee: Protease Sciences, Inc.
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5794612
    Abstract: An intrapulmonary delivery device is provided for delivery of a propellant driven medicament. The device has an indicating system with a sensor responsive to a selected range of ultrasound, a controller associated with the sensor for signalling the detected ultrasound, a differential pressure sensor and a display for the signals. The controller is associated with a microprocessor where the signal level the duration and time of actuation is stored in memory.
    Type: Grant
    Filed: April 2, 1997
    Date of Patent: August 18, 1998
    Assignee: Aeromax Technologies, Inc.
    Inventors: Allan Wachter, Stuart Lindsay
  • Patent number: 5780440
    Abstract: The invention relates to methods and compositions for the prevention or treatment of patients suffering from respiratory distress syndrome and/or sepsis syndrome by administering directly into the lungs small or nicrocrystalline particles or droplets of at least one protease inhibitor alone or with an oxygen metabolite scavenger. The method can also include the treatment in combination with the monitoring of the urine desmosine level of the patients and the use of DNase.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: July 14, 1998
    Assignee: Protease Sciences Inc.
    Inventors: John Lezdey, Allan Wachter, Barry Starcher
  • Patent number: 5532215
    Abstract: The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their analogs, salts, conjugates or derivatives.
    Type: Grant
    Filed: October 3, 1994
    Date of Patent: July 2, 1996
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5492889
    Abstract: There is provided a method for treating tumors in mammals by the administration of alpha 1-antitrypsin alone or in combination with other protease inhibitors.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: February 20, 1996
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5376633
    Abstract: The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their analogs, salts, conjugates or derivatives.
    Type: Grant
    Filed: September 15, 1993
    Date of Patent: December 27, 1994
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5346886
    Abstract: The invention provides a pharmaceutical composition for the treatment of a mammal having a skin disease. The composition contains a serine protease inhibitor and an effective amount of a cationic quaternary ammonium salt at a concentration below the critical micelle concentration for increasing the penetration of the inhibitor in the skin. Additionally, these may be included an ethoxylated nonylphenol.
    Type: Grant
    Filed: November 15, 1993
    Date of Patent: September 13, 1994
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5290762
    Abstract: A method for the prophylaxis or direct treatment of inflammatory diseases or injuries in a patient which comprises administering to the site of the disease or injury an effective amount of at least one serine protease inhibitor, its salts, derivatives or analogs which bind with the mast cell mediators, T-cell mediators or kallikrein.
    Type: Grant
    Filed: February 17, 1993
    Date of Patent: March 1, 1994
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5114917
    Abstract: A method for the prophylaxis or direct treatment of inflammation in a mammal which comprises administering an effective amount of alpha 1-antichymotrypsin, its salts or derivatives, and compositions thereof.
    Type: Grant
    Filed: October 2, 1990
    Date of Patent: May 19, 1992
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5093316
    Abstract: A method for treating pulmonary inflammation and alpha-1-antitrypsin deficiencies by the administration of an effective amount of microcrystalline alpha-1-antitrypsin, its salt or derivative by inhalation, alone or with other serine protease inhibitors, and the pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 2, 1990
    Date of Patent: March 3, 1992
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 5008242
    Abstract: A method for the prophylaxis or direct treatment of inflammation in a mammal or fowl which comprises administering an effective amount of alpha 1-antichymotrypsin, its salts or derivatives.
    Type: Grant
    Filed: December 4, 1989
    Date of Patent: April 16, 1991
    Inventors: John Lezdey, Allan Wachter
  • Patent number: 4916117
    Abstract: A method for treating pulmonary and/or bowel inflammation in mammals by the administration of an effective amount of alpha 1-antichymotrypsin, its salt or derivative, and the pharmaceutical compositions therefor.
    Type: Grant
    Filed: April 14, 1988
    Date of Patent: April 10, 1990
    Inventors: John Lezdey, Allan Wachter